ATRA Atara Biotherapeutics, Inc.

NASDAQ
$8.81

Atara Biotherapeutics, Inc. (ATRA) is expected to report earnings on November 9, 2026, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of +5.6% since its last earnings release on August 12, 2026.

Atara Biotherapeutics Reported Earnings
Wednesday, August 12, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 4:05 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $9.37

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Atara Biotherapeutics, Inc.

Atara Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing novel therapeutics for serious unmet medical needs which focuses on muscle wasting conditions and oncology.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.